Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000950170-25-063886

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dupont Jakob Director 2025-05-01 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…